SODIUM PHENYLACETATE AND SODIUM BENZOATE
Generic: SODIUM PHENYLACETATE AND SODIUM BENZOATE
MAIA PHARMACEUTICALSManufacturer
INTRAVENOUSRoute
SODIUM PHENYLACETATEActive Substance
2017-05-08Original Approval
SODIUM PHENYLACETATE AND SODIUM BENZOATE is FDA application ANDA208521, sponsored by MAIA PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
5 reports
2
HYPERGLYCAEMIA
2 reports
3
AMMONIA DECREASED
1 reports
4
ANION GAP INCREASED
1 reports
5
BLOOD LACTIC ACID INCREASED
1 reports
6
BRAIN OEDEMA
1 reports
7
CEREBRAL INFARCTION
1 reports
8
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION
1 reports
9
MATERNAL EXPOSURE DURING PREGNANCY
1 reports
10
MYCOPLASMA TEST POSITIVE
1 reports